Table 1. Receptor Interactions and Binding Energies of the Tested Anthelmintic Drugs (1–13) and the Docked Benzimidazole–Urea Inhibitor (14) at the Binding Site of the VEGFR-2 Receptor.
| no. | anthelmintic drug | Sa | rmsdb | amino acid bonds | distance (A) |
|---|---|---|---|---|---|
| 1 | fenbendazole | –8.18 | 1.08 | Leu838/H2O bridged H bond | 2.74 |
| Leu838/H2O bridged H bond | 2.89 | ||||
| Cys917/H-donor | 2.96 | ||||
| Cys917/H-acceptor | 3.12 | ||||
| Leu838/pi-H | 3.98 | ||||
| Val846/pi-H | 4.69 | ||||
| 2 | mebendazole | –8.12 | 0.93 | Leu838/H2O bridged H bond | 2.68 |
| Leu838/H2O bridged H bond | 2.93 | ||||
| Cys917/H-donor | 2.97 | ||||
| Cys917/H-acceptor | 3.08 | ||||
| Leu838/pi-H | 4.03 | ||||
| 3 | albendazole | –7.91 | 1.15 | Leu838/H2O bridged H bond | 2.74 |
| Leu838/H2O bridged H bond | 2.90 | ||||
| Cys917/H-donor | 3.01 | ||||
| Cys917/H-acceptor | 3.12 | ||||
| Leu838/pi-H | 4.01 | ||||
| 4 | ricobendazole | –7.85 | 1.31 | Leu838/H2O bridged H bond | 2.77 |
| Cys917/H-donor | 2.89 | ||||
| Leu838/H2O bridged H bond | 2.99 | ||||
| Cys917/H-acceptor | 3.03 | ||||
| Leu838/pi-H | 4.09 | ||||
| 5 | cyclobendazole | –7.60 | 1.66 | Leu838/H2O bridged H bond | 2.83 |
| Cys917/H-donor | 2.86 | ||||
| Leu838/H2O bridged H bond | 2.97 | ||||
| Cys917/H-acceptor | 3.02 | ||||
| Leu838/pi-H | 4.06 | ||||
| 6 | oxibendazole | –7.58 | 1.05 | Cys917/H-donor | 2.80 |
| Leu838/H2O bridged H bond | 2.92 | ||||
| Cys917/H-acceptor | 3.09 | ||||
| Leu838/pi-H | 4.03 | ||||
| 7 | oxfendazole | –7.54 | 1.69 | Leu838/H2O bridged H bond | 2.75 |
| Cys917/H-acceptor | 3.63 | ||||
| Leu838/pi-H | 4.04 | ||||
| 8 | dribendazole | –7.53 | 1.31 | Cys917/H-donor | 2.85 |
| Leu838/H2O bridged H bond | 2.91 | ||||
| Cys917/H-acceptor | 3.06 | ||||
| Leu838/pi-H | 4.03 | ||||
| Val846/pi-H | 4.82 | ||||
| 9 | parbendazole | –7.46 | 1.06 | Cys917/H-donor | 2.80 |
| Leu838/H2O bridged H bond | 2.92 | ||||
| Cys917/H-acceptor | 3.05 | ||||
| Leu838/pi-H | 4.06 | ||||
| Val846/pi-H | 4.72 | ||||
| 10 | bendazole | –6.84 | 0.70 | ||
| 11 | tiabendazole | –6.62 | 0.59 | Leu838/H2O bridged H bond | 2.82 |
| Leu838/H2O bridged H bond | 2.92 | ||||
| Cys917/H-acceptor | 3.30 | ||||
| Leu838/pi-H | 3.97 | ||||
| 12 | triclabendazole | –6.40 | 1.18 | Leu838/H2O bridged H bond | 2.83 |
| Cys917/H-acceptor | 3.22 | ||||
| Leu838/pi-H | 3.89 | ||||
| 13 | flubendazole | –5.94 | 1.05 | Leu838/H2O bridged H bond | 2.72 |
| Leu838/H2O bridged H bond | 2.88 | ||||
| Cys917/H-donor | 2.96 | ||||
| Cys917/H-acceptor | 3.09 | ||||
| Leu838/pi-H | 4.06 | ||||
| Val846/pi-H | 4.78 | ||||
| 14 | benzimidazole urea inhibitor (GIG) | –11.15 | 1.39 | Cys917/H-donor | 2.82 |
| Glu883/H-donor | 2.86 | ||||
| Glu883/H-donor | 2.89 | ||||
| Leu838/H2O bridged H bond | 2.92 | ||||
| Asp1044/H-acceptor | 2.94 | ||||
| Cys917/H-acceptor | 3.10 | ||||
| Leu838/pi-H | 4.02 |
S: score of a compound inside the binding pocket of protein (kcal/mol).
rmsd/refine: root-mean-square deviations among heavy atoms of crystallized structure (prerefinement) and those of the obtained binding mode (postrefinement).